Viewing Study NCT00911066


Ignite Creation Date: 2025-12-24 @ 4:37 PM
Ignite Modification Date: 2026-02-02 @ 5:25 AM
Study NCT ID: NCT00911066
Status: COMPLETED
Last Update Posted: 2013-12-05
First Post: 2009-05-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia
Sponsor: Millennium Pharmaceuticals, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: C15003
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators